The Covid-19 pandemic put human challenge trials in the spotlight, drawing attention to this design’s possibilities in infectious disease studies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,